Bioequivalence of generic drugs.
Andrade C.
J Clin Psychiatry. 2015 Sep;76(9):e1130-1. doi: 10.4088/JCP.15f10300.
Bio-generics.
[No authors listed]
Ocul Surf. 2006 Jul;4(3):163-4. doi: 10.1016/s1542-0124(12)70044-7.
Narrow Therapeutic Index Drugs: FDA Experience, Views, and Operations.
Donnelly M, Fang L, Madabushi R, Zhu H, Luke M, Canterbury C, Lerman B, Kaur P, Patel D, Sun W, Schuirmann D, Dinsmore S, Mehta M, Zhao L.
Clin Pharmacol Ther. 2025 Jan;117(1):116-129. doi: 10.1002/cpt.3460. Epub 2024 Nov 11.
BIOSIMILAR DRUGS ARE NOT GENERICS.
Zangeneh F, Dolinar R.
Endocr Pract. 2016 Jan;22(1):6-7. doi: 10.4158/EP151135.ED.
Generically speaking.
[No authors listed]
Drug Ther Bull. 2009 Oct;47(10):109. doi: 10.1136/dtb.2009.09.0039.
Branded generics.
Somberg JC.
J Clin Pharmacol. 1993 Sep;33(9):779. doi: 10.1002/j.1552-4604.1993.tb01951.x.
Evergreened drugs or evergreened profits?
Siddalingaiah S, Fugh-Berman A.
J Eval Clin Pract. 2022 Dec;28(6):1119-1126. doi: 10.1111/jep.13695. Epub 2022 May 11.
Evaluating the bioequivalence of clopidogrel generic formulations.
Tsoumani ME, Ntalas IV, Goudevenos JA, Tselepis AD.
Curr Med Res Opin. 2015 May;31(5):861-4. doi: 10.1185/03007995.2015.1028912. Epub 2015 Apr 1.
What price change?
[No authors listed]
Drug Ther Bull. 2014 Feb;52(2):13. doi: 10.1136/dtb.2014.2.0232.
Demystifying bioequivalence.
Weekes LM.
Med J Aust. 2014 Aug 18;201(4):188. doi: 10.5694/mja14.00904.
